. 2016 May 24;5:54. doi: 10.1186/s40249-016-0147-4

Table 9.

Projected health impact of the GPELF (2000–2014) over lifetime of the benefit cohorts

Benefit cohort	Number of chronic cases averted (millions)	Years of chronic disease averted (millions)	Number of acute (ADL) episodes averted (millions)	DALYs averted (millions)^a
1. Protected from acquiring infection	21	938	2,157	103 (68–147)
2. Subclinical morbidity prevented from progressing	12	551	1,267	62 (41–88)
3. Alleviated clinical disease	3	104	1,264	11 (8–16)
Total	36	1,592	4,689	175 (116–250)

^aRange based on the 95 % uncertainty interval of the disability weight (Table 7)

See Additional file 2: Table S3 for the results stratified by WHO region. ADL acute adenolymphangitis